The Antibody Society, in collaboration with the Ovarian Cancer Research Alliance (OCRA), is pleased to present the Emerging Immunotherapeutics for Ovarian Cancer Symposium. The mission of OCRA is to cure ovarian cancer, advocate for patients, and support survivors. The aim of this event is to spread knowledge and awareness around current and up-and-coming basic and clinical research on the use of antibody and immune therapeutics for the treatment of ovarian cancer. See below for the expert speaker line-up and agenda.
Registration is free for The Antibody Society Members and Corporate Sponsors. Contact us at firstname.lastname@example.org for the 100% discount code.
Registration for non-members is $50.00. The Antibody Society will donate the registration fees to OCRA. We also encourage you to donate directly to OCRA via this link to the Ovarian Cancer Research Alliance.